| pubmed-article:15949597 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0149925 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C1518965 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C1705294 | lld:lifeskim |
| pubmed-article:15949597 | lifeskim:mentions | umls-concept:C1518422 | lld:lifeskim |
| pubmed-article:15949597 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15949597 | pubmed:dateCreated | 2005-6-13 | lld:pubmed |
| pubmed-article:15949597 | pubmed:abstractText | High risk patients with metastatic non small cell lung cancer (NSCLC) including patients with performance status (PS) 2 or elderly with comorbidities do poorly on combination chemotherapy regimens. We evaluated a sequential treatment with Vinorelbine followed by Gemcitabine to determine its effect on survival and the toxicity in this patient population. | lld:pubmed |
| pubmed-article:15949597 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15949597 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949597 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15949597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949597 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15949597 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15949597 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15949597 | pubmed:issn | 0169-5002 | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:FoxSusanS | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:PintosJavierJ | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:HirshVeraV | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:WhittomRenaud... | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:OfiaraLindaL | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:DesjardinsPie... | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:LatreilleJean... | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:KreismanHarve... | lld:pubmed |
| pubmed-article:15949597 | pubmed:author | pubmed-author:PalayewMark... | lld:pubmed |
| pubmed-article:15949597 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15949597 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:15949597 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15949597 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15949597 | pubmed:pagination | 117-23 | lld:pubmed |
| pubmed-article:15949597 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:meshHeading | pubmed-meshheading:15949597... | lld:pubmed |
| pubmed-article:15949597 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15949597 | pubmed:articleTitle | Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial. | lld:pubmed |
| pubmed-article:15949597 | pubmed:affiliation | Royal Victoria Hospital, McGill University, 687 Pine Avenue W, Montreal, Que., Canada H3A 1A1. vera.hirsh@muhc.mcgill.ca | lld:pubmed |
| pubmed-article:15949597 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15949597 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15949597 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15949597 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:15949597 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
